Neonatal screening or Newborn Screening involves the screening of newborns in the first days of their lives for inborn errors of metabolism and certain disorders that can hinder the normal development of the baby. These disorders, are not apparent at the time of the baby's birth, but have potential to cause permanent neurological, cognitive, tactile and physical damage in the child. Early detection of such diseases enable initiating of suitable interventions to prevent concerning conditions in the long run. Trivitron provides a wide range Newborn Screening instruments, including Modular & Fully Automated NBS Instrumentation, manual & automated equipment and reagent kits. Trivitron's Diagnostic division Labsystems Diagnostics OY occupies the second place in the world when it comes to New Born Screening Technology.
Fluoro Enzymatic Assays
Labsystems Diagnostics' Neonatal Biotinidase kit is for enzymatic determination of biotinidase enzyme activity from blood samples dried on filter paper, with fluorometric detection, intended for newborn screening for biotinidase deficiency. Read More
Labsystems Diagnostics' Neonatal G6PD is an enzymatic method for the quantitative determination of glucose-6-phosphate dehydrogenase activity in blood samples dried on filter paper, with fluorometric detection, intended for newborn screening of glucose-6-phosphate dehydrogenase deficiency. Read More
Labsystems Diagnostics' Neonatal Galactose is a quantitative fluorometric test for the total galactose from dried blood spot samples. The test is based on the combined determination of free and galactose liberated from the cleavage of the galactose-1-phosphate. Read More
Labsystems Diagnostics' test is designed for the quantitative in vitro determination of galactose-1-phosphate uridyltransferase (GALT) activity in blood samples dried on filter paper. This kit is intended for screening newborns for classic galactosemia, which is caused by the inability to convert Galactose-1-phosphate into glucose-1-phosphate due to GALT deficiency. Read More
Labsystems Diagnostics is the first company in the world to introduce fluorometric microplate based assay for phenylalanine for diagnosing phenylketonuria (PKU) in newborns. Its pioneered Newborn Screening products and systems are based on fluorescence and photometric detections. All the reagent kits can be used manually in modular systems or in fully automated and hands off systems.
Labsystems Diagnostics' Neonatal 17-OH-Progesterone FEIA test is a fluorometric enzyme immunoassay enabling the quantification of 17-hydroxyprogestrone steroid present in blood samples dried on filter paper. The test can be used for the screening of newborn for Congenital Adrenal Hyperplasia (CAH). Read More
Labsystems Diagnostics' Neonatal hTSH FEIA Plus is a fluorometric enzyme immunoassay for the quantitative determination of human thyroid stimulating hormone (hTSH, human thyrotropin) in blood samples dried on filter paper as a primary test for screening of babies for congenital hypothyroidism (CH). Read More
Labsystems Diagnostics' Neonatal IRT FEIA is a fluorometric enzyme immunoassay for the quantitative determination of human immuno reactive trypsinogen (IRT) from blood samples dried on filter paper as a primary test for screening of babies for cystic fibrosis (CF). Read More
Fluorometric enzyme immunoassay for the quantitative determination of total Thyroxine (T 4) from blood samples dried on filter paper as a primary test for screening of babies for congenital hypothyroidism (CH). Read More
Labsystems Diagnostics' Neonatal Toxoplasma gondii IgM FEIA is a fluorometric enzyme immunoassay intended for the determination of IgM-class antibodies to Toxoplasma gondii in blood samples dried on filter paper. The test is intended as a primary method for screening newborns for congenital toxoplasmosis (CT). Read More
To run a successful and cost-effective newborn screening test, there is a requirement for all the instruments and reagents. Trivitron's Labsystems Diagnostics Oy delivers the most sophisticated fully-automated solutions in the highest quality and performance standards, ensuring the highest levels of performance for your lab.
REVOLUTIONARY NS2400 NEONATAL SCREENING AUTOMATE With 25 plate capacity, 10 Assays on board, NS2400 automates the highest throughput sites or can handle the highest workload with extremely flexible, could be customized to your needs Read More
A versatile tool for Newborn Screening with high format flexibility and detection sensibility. Read More
Labsystems Diagnostics introduced world's first fluorometric microplate based assay for screening Phenyl Alanine in newborns to detect Phenylketonuria (PKU) and now on tandem MS along with more than 50 disorders. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) increased the screening possibilities by monitoring levels of amino acids and acylacarnitines. These tests can also be used in screening positive samples as a second tier confirmation test to differentiate between true and false positive samples. LC-MS/MS can detect several disorders with a single injection, which is important in high throughput labs.
2nd tier LC-MS/MS Kit for Congenital Adrenal Hyperplasia.Congenital adrenal hyperplasia (CAH) refers to a group of autosomal recessive disorders that impair cortisol biosynthesis. CAH represents a continuous phenotypic spectrum with over 95% of all cases caused by 21-hydroxylase deficiency. CAH owing to 21-hydroxylase deficiency is the most common cause of genital ambiguity in the newborn and is present in about 1 in 15,000 live births worldwide Read More
NeoMass AAAC is used with Tandem Mass Spectrometry to detect concentrations of amino acid, free carnitine, acylcarnitines, succinylacetone and argininosuccinic acid. Read More
A thyroid stimulating hormone (TSH) test is a common blood test used to evaluate how well the thyroid gland is working. For newborns and infants, thyroid hormone is crucial for normal growth and development of the body and brain. TSH Point of birth tests are routinely ordered for newborns across the world as a part of the newborn screening program to enable prompt diagnosis and treatment.